Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

621878

registered interest
date	26/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Continuing Care
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether NHS-funded continuing healthcare is available for hospice patients receiving palliative care; and what distinction, if any, is drawn between patients in hospices and those in nursing homes in determining the availability of continuing healthcare.
tabling member printed	Baroness Massey of Darwen
uin	HL2684
answer	answer is ministerial correction date of answer 08/11/2016 answer text <p>Eligibility for NHS Continuing Healthcare (NHS CHC) is not limited by the setting in which the package of support can be offered or by the type of service delivery.</p><p> </p><p>When making decisions about eligibility for NHS CHC there is no distinction drawn between individuals residing in hospices and those in nursing homes.</p> answering member printed Lord Prior of Brampton question first answered 08/11/2016 15:13:07 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2489 label Biography information for Baroness Massey of Darwen

621911

registered interest
date	26/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners: Retirement
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many general practitioners in England retired during the past 12 months; and, of those, how many were aged under 60 at the time of retirement.
tabling member printed	Lord Wigley
uin	HL2717
answer	answer is ministerial correction date of answer 08/11/2016 answer text <p>For the last 12 months for which data is available, (the period 1 April 2015 to 31 March 2016) 992 general practitioners retired and claimed retirement benefits from the NHS Pension Scheme in England and Wales.</p><p> </p><p>Of these, 580 were under 60 years of age.</p><p> </p><p>General practitioners, in common with other staff groups, are able to claim retirement benefits and return to the National Health Service. This may be on a full time or part-time basis. This is common practice but exact numbers are not known.</p> answering member printed Lord Prior of Brampton question first answered 08/11/2016 15:11:45 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	547 label Biography information for Lord Wigley

621936

registered interest
date	26/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 11 July 2016 (HL1098), whether the correspondence between Professor Grifo and the Human Fertilisation and Embryology Authority (HFEA) expert panel was selectively released to anyone not directly connected with the HFEA; whether other information received by the HFEA has been selectively released to such persons but not otherwise made publicly available; and if so, what assessment they have made of the extent to which conflicts of interest might arise from the selective release of such material.
tabling member printed	Lord Alton of Liverpool
uin	HL2742
answer	answer is ministerial correction date of answer 07/11/2016 answer text <p>The Human Fertilisation and Embryology Authority has advised that it has nothing further to add, in respect of the correspondence between Professor Grifo and the expert panel, to that already set out in previous answers.</p> answering member printed Lord Prior of Brampton grouped question UIN HL2544 HL2611 question first answered 07/11/2016 14:22:33 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	738 label Biography information for Lord Alton of Liverpool

621944

registered interest
date	26/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Foreign Nationals
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is the anual cost to the NHS of (1) people coming to the UK from overseas to receive non-emergency medical treatment, and (2) non-UK residents receiving emergency healthcare; and how many such persons are estimated to travel to the UK specifically for the purpose of accessing NHS services.
tabling member printed	The Marquess of Lothian
uin	HL2750
answer	answer is ministerial correction date of answer 01/11/2016 answer text <p>The Department does not hold data that distinguishes emergency from non-emergency healthcare provided to patients subject to the NHS (Charges to Overseas Visitors) Regulations 2015.</p><p> </p><p>The Department does not hold information on the numbers of persons estimated to travel to the United Kingdom specifically for the purpose of accessing National Health Service services.</p> answering member printed Lord Prior of Brampton question first answered 01/11/2016 16:11:45 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	259 label Biography information for The Marquess of Lothian

621947

registered interest
date	26/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Records: Data Protection
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government which of the recommendations of the Review by the National Data Guardian for Health and Care of Data Security, Consents and Opt-Outs published in June they intend to treat as formal recommendations to which they will provide a response.
tabling member printed	Lord Hunt of Kings Heath
uin	HL2753
answer	answer is ministerial correction date of answer 03/11/2016 answer text <p>The Department welcomed Dame Fiona Caldicott’s <em>Review of Data Security, Consents and Opt-Outs</em> and, following conclusion of a public consultation exercise, will respond to all recommendations in due course.</p> answering member printed Lord Prior of Brampton question first answered 03/11/2016 13:28:16 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

621975

registered interest
date	26/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cholesterol: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the innovative potential of PCSK9 inhibitor medicines for the treatment of high levels of cholesterol.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	50562
answer	answer is ministerial correction date of answer 02/11/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) has appraised the PCSK9 inhibitors alirocumab (Praluent) and evolocumab (Repatha) for treating primary hypercholesterolaemia and mixed dyslipidaemia. In June 2016, NICE issued final technology appraisal guidance recommending both treatments, subject to certain criteria. Further information is available at:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/conditions-and-diseases/diabetes-and-other-endocrinal--nutritional-and-metabolic-conditions/lipid-disorders" target="_blank">www.nice.org.uk/guidance/conditions-and-diseases/diabetes-and-other-endocrinal--nutritional-and-metabolic-conditions/lipid-disorders</a></p><p> </p><p>NHS Commissioners are legally required to fund drugs and treatments recommended in NICE technology appraisal guidance within three months of its final guidance being issued.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 50629 question first answered 02/11/2016 14:10:41 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1604 label Biography information for Mr Virendra Sharma

621976

registered interest
date	26/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to encourage the adoption of a personalised approach to medicines (a) in general and (b) in the treatment of familial hypercholesterolemia.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	50611
answer	answer is ministerial correction date of answer 03/11/2016 answer text <p>The Government is committed to embedding the use of genomic technologies and personalised medicine in healthcare. Through significant investment the 100,000 Genomes Project and the establishment of 13 NHS Genomics Medicine Centres, the National Health Service is at the forefront of the collection and use of whole genomes sequence data on a large scale. The project covers cancer and rare diseases including familial hypercholesterolemia.</p><p> </p><p>NHS England published ‘Improving Outcomes though Personalised Medicine’ on 7 September 2016:</p><p> </p><p><a href="https://www.england.nhs.uk/ourwork/qual-clin-lead/personalisedmedicine/" target="_blank">https://www.england.nhs.uk/ourwork/qual-clin-lead/personalisedmedicine/</a></p><p> </p><p>This document sets out the vision for embedding personalised medicine within healthcare provision and explains how the use of genomics and other diagnostics can be used to identify people most at risk of diseases such as familial hypercholesterolemia before the onset of their symptoms.</p><p> </p><p>The National Institute of Health and Care Excellence has also published clinical guidelines on the identification and management of adults and children with familial hypercholesterolemia. These guidelines are currently being reviewed and updated.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 03/11/2016 17:00:36 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1604 label Biography information for Mr Virendra Sharma

621977

registered interest
date	26/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cardiovascular Diseases: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he has made an assessment of the effect of the Cardiovascular Outcomes Strategy on patient outcomes since its publication.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	50504
answer	answer is ministerial correction date of answer 01/11/2016 answer text <p>No formal assessment has been made of the effect of the Cardiovascular Disease (CVD) Outcomes Strategy on patient outcomes.</p><p> </p><p>However, NHS England continues to support a number of national clinical audits which provide the information to enable commissioners to assess the quality of local services, including in relation to heart disease, stroke and diabetes.</p><p> </p><p>NHS England hosts a CVD outcomes collaborative which brings together the relevant National Clinical Directors, the main relevant national charities, NHS Improving Quality, the National CVD Intelligence Network, Public Health England and the Department. This collaborative continues to coordinate delivery of the work which was initiated in the CVD Outcomes Strategy.</p> answering member constituency Warrington South answering member printed David Mowat question first answered 01/11/2016 14:16:53 answering member 4080 label Biography information for David Mowat
tabling member	1604 label Biography information for Mr Virendra Sharma

621992

registered interest
date	26/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Veterans
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effectiveness of prioritising NHS treatment for armed forces veterans.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	50620
answer	answer is ministerial correction date of answer 31/10/2016 answer text <p>No assessment has been made of the effectiveness of prioritising National Health Service treatment for Armed Forces veterans. Priority treatment for veterans relates to health requirements resulting from their time in the Armed Forces and is subject to clinical needs of others. Decisions are therefore made on an individual basis and subject to the clinical judgement of those involved. We are working with the Royal British Legion to consider what more can be done to raise awareness of the priority treatment process for veterans with service related health needs.</p> answering member constituency Warrington South answering member printed David Mowat question first answered 31/10/2016 16:32:10 answering member 4080 label Biography information for David Mowat
tabling member	4122 label Biography information for Alex Cunningham

622012

registered interest
date	26/10/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Department of Health: UN Convention on the Rights of the Child
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Written Ministerial Statement of 6 December 2010, Col 7WS, what consideration his Department has given to the articles of the UN Convention on the Rights of the Child when making new policy and legislation since May 2015.
tabling member constituency	Workington
tabling member printed	Sue Hayman
uin	50472
answer	answer is ministerial correction date of answer 31/10/2016 answer text <p>The Department recognises the importance of considering the articles of the United Nations Convention on the Rights of the Child when making new policy and legislation.</p><p> </p><p>Alongside other Government Departments we report every five years to the UN Committee on our compliance. Following the most recent oral hearing in May 2016, the UN Committee has made a number of concluding observations. We will be able to demonstrate progress against these observations during the next reporting round.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 31/10/2016 18:03:00 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4395 label Biography information for Baroness Hayman of Ullock